The Timing of Preclinical Toxicological Studies: Pharmaceutical Company Approaches to Toxicity Testing in Support of Initial Clinical Investigations

Author： Parkinson C.   Thomas K.E.   Lumley C.E.  

Publisher： Academic Press

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.23, Iss.2, 1996-04, pp. : 162-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Piperine: A Comprehensive Review of Pre-Clinical and Clinical Investigations

By  

Current Bioactive Compounds, Vol. 11, Iss. 3, 2015-09 ,pp. : 156-169

Bentham Science Publishers

Access to resources Recommend Favorite

Non-clinical toxicological considerations for pharmaceutical salt selection

By Thackaberry Evan A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1419-1433

Informa Healthcare

Access to resources Recommend Favorite

Aurora kinase inhibitors in preclinical and clinical testing

By Cheung Chun Hei Antonio   Coumar Mohane Selvaraj   Hsieh Hsing-Pang   Chang Jang-Yang  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 379-398

Informa Healthcare

Access to resources Recommend Favorite

Making Progress in the Acute Treatment of Stroke: Preclinical and Clinical Challenges for Pharmaceutical Medicine

By James Michael F.  

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 2, 2005-01 ,pp. : 77-88

Adis International

Access to resources Recommend Favorite

Amorphous Active Pharmaceutical Ingredients in Preclinical Studies: Preparation, Characterization, and Formulation

By  

Current Bioactive Compounds, Vol. 4, Iss. 4, 2008-12 ,pp. : 213-224

Bentham Science Publishers

Access to resources Recommend Favorite